Gene therapy may require multi-stage drug delivery systems

August 04, 2009 | Analyst Insight

At the SMi Controlled Release conference in London last week, we spoke with Andrew Miller, Director of the Imperial College London Genetic Therapies Centre. Andrew is working on “soft, triggerable nanoparticles” for...